文献速递艾滋病与性传播感染

HIV感染者干血斑中替诺福韦二磷酸浓度相关因素

Factors associated with tenofovir diphosphate concentrations in dried blood spots in persons living with HIV.
PubMed 文献 · J Antimicrob Chemother · 2020-01-01

结果显示,3个月自我报告依从性每增加10%,TFV-DP浓度平均升高28%(95%CI 24%-32%,P<0.0001);女性较男性高20%(95%CI 3%-40%,P=0.02);BMI每增加1 kg/m2,浓度降低2%(95%CI -3%至-1%,P<0.0001)。

要点

  • 自我报告依从性每增10%,DBS中TFV-DP浓度平均升高28%。
  • 女性TFV-DP浓度较男性高20%,BMI每增1 kg/m2浓度降2%。
  • 解读DBS TFV-DP依从性生物标志物时需考虑性别与BMI。

核心结论

  • 在接受TDF方案治疗的HIV感染者中,个体特征可预测DBS中TFV-DP浓度。

主要发现

  • 调整种族和其他临床协变量后,3个月自我报告依从性每增加10%,DBS中TFV-DP浓度平均升高28%(95%CI 24%-32%,P<0.0001)。
  • 同一模型中,女性DBS中TFV-DP浓度较男性高20%(95%CI 3%-40%,P=0.02)。
  • BMI每增加1 kg/m2,DBS中TFV-DP浓度降低2%(95%CI -3%至-1%,P<0.0001)。

临床怎么用

  • 临床解读DBS中TFV-DP作为依从性生物标志物时,应结合患者性别和BMI等个体特征。

局限性

  • 研究仅纳入接受TDF方案者,结论是否适用于替诺福韦艾拉酚胺(TAF)方案尚需研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine factors associated with interindividual variability in tenofovir diphosphate (TFV-DP) concentrations in dried blood spots (DBSs) among persons living with HIV (PLWH). METHODS: PLWH who were at least 18 years old and taking tenofovir disoproxil fumarate-containing ART were prospectively recruited and enrolled from a clinical cohort and followed longitudinally (up to three visits over 48 weeks). With log-transformed TFV-DP concentrations in DBSs as the outcome, mixed-model regression analyses were used to assess associations between self-reported 3 month ART adherence, race and other clinical covariates (gender, age, BMI, CD4+ T cell count, estimated glomerular filtration rate, haematocrit, duration on current ART and anchor drug class) on TFV-DP in DBSs. RESULTS: Five hundred and twenty-seven participants (1150 person-visits) were analysed. Adjusting for race and other clinical covariates, every 10% increase in self-reported 3 month ART adherence was associated with an average TFV-DP concentration increase in DBSs of 28% (95% CI: 24%-32%; P < 0.0001). In the same model, female participants had 20% (95% CI: 3%-40%; P = 0.02) higher TFV-DP concentrations in DBSs, compared with male participants, and every 1 kg/m2 increase in BMI was associated with a decrease in TFV-DP concentration in DBSs by 2% (95% CI: -3% to -1%; P < 0.0001). CONCLUSIONS: Individual patient characteristics were predictive of TFV-DP concentration in DBSs in PLWH receiving tenofovir disoproxil fumarate-based ART. Future research to incorporate these predictors into the interpretation of this ART adherence biomarker, and to establish whether these associations extend to PLWH taking tenofovir alafenamide-containing ART, is needed.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Coyle RP, Morrow M, Coleman SS, et al. Factors associated with tenofovir diphosphate concentrations in dried blood spots in persons living with HIV. J Antimicrob Chemother. 2020. PMID: 32211787. doi:10.1093/jac/dkaa070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。